Yin Wang

iASPP induces EMT and cisplatin resistance in human cervical cancer through miR-20a-FBXL5/BTG3 signaling

P. Dong, H. Watari, J. Yue, 2017, Journal of experimental & clinical cancer research : CR.

Neoadjuvant chemotherapy followed by conization to spare fertility in cases of locally advanced cervical cancer: A case report and review of the literature.

He Huang, Jihong Liu, Yanling Feng, 2016, Molecular and clinical oncology.

Tumor-induced VEGF-C overexpression in retroperitoneal lymph nodes in VX2 carcinoma-bearing rabbits

Ji-Hong Liu, C. Lan, R. Luo, 2015, Drug design, development and therapy.

Multiparametric immune profiling of advanced cervical cancer to predict response to programmed death-1 inhibitor combination therapy: an exploratory study of the CLAP trial

Hongyu Peng, Xin Huang, Shumei Yan, 2022, Clinical and Translational Oncology.

Apatinib combined with oral etoposide in patients with platinum-resistant or platinum-refractory ovarian cancer (AEROC): a phase 2, single-arm, prospective study.

M. Zheng, Jingxian Shen, Y. Xiong, 2018, The Lancet. Oncology.

Camrelizumab Plus Apatinib in Patients With Advanced Cervical Cancer (CLAP): A Multicenter, Open-Label, Single-Arm, Phase II Trial

Wei Wei, M. Zheng, Qing Liu, 2020, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Should the Optimal Adjuvant Treatment for Patients With Early-Stage Endometrial Cancer With High-Intermediate Risk Factors Depend on Tumor Grade?

C. Lan, Xin Huang, Jihong Liu, 2015, International Journal of Gynecologic Cancer.

Efficacy and safety of sintilimab plus albumin-bound-paclitaxel in recurrent or metastatic cervical cancer: a multicenter, open-label, single-arm, phase II trial

C. Lan, Yin Wang, Shenjiao Huang, 2023, EClinicalMedicine.